FDA Import Refusal 799-5133554-8/30002/1 — Boehringer Ingelheim S.A.
The FDA refused shipment 799-5133554-8/30002/1 from Boehringer Ingelheim S.A. (Colombia) on November 25, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- November 25, 2025
- Country
- Colombia
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75